<DOC>
	<DOCNO>NCT01137292</DOCNO>
	<brief_summary>Assessment safety efficacy voriconazole real-life setting treatment high risk patient invasive fungal infection . The study conduct Slovakia .</brief_summary>
	<brief_title>Open , Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Male female patient age 2 year old . Highrisk patient proven , probable possible invasive fungal infection ( IFI ) accord EORTC/MSG criterion . Patients indicate secondary prophylaxis invasive aspergillosis . Patients know hypersensitivity voriconazole excipients . Patients contraindicate concomitant medication accord SmPC . Children le 2 year age . Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>observational study</keyword>
	<keyword>voriconazole</keyword>
	<keyword>high-risk patient</keyword>
</DOC>